Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination

Date: 09/13/2021

Product type: Drugs, Potential Foreign Material

Company Announcement Date: September 13, 2021
FDA Publish Date: September 13, 2021
Product Type: Drugs
Reason for Announcement: Exceeds Specification for Total Yeast and Mold Counts
Company Name: Jacobus Pharmaceutical Company Inc.
Brand Name: Ruzurgi®
Product Description: Ruzurgi® (amifampridine) 10 mg tablets

US-FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg